News & Events

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first immunotherapy against cancer. And it is still used today to treat early-stage bladder cancer.

Now, a team of researchers from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center (MSK) is expanding the understanding of how the...

Four Weill Cornell Medicine investigators received the Ritu Banga Healthcare Disparities Research Awards, recognizing innovative research that will help close care gaps in clinical settings. Endowed through a generous $5 million gift from Board of Fellows member Ritu Banga and her husband, Ajay Banga, each $50,000 award supports projects aimed at improving health outcomes for populations that have historically faced systemic barriers to care.

“It is an honor to help bring to life the...

Researchers at Weill Cornell Medicine have discovered how a parasite that causes malaria when transmitted through a mosquito bite can hide from the body’s immune system, sometimes for years. It turns out that the parasite, Plasmodium falciparum, can shut down a key set of genes, rendering itself “immunologically invisible.”

For six years, Dr. Benjamin Allwein studied to be a scientist at Weill Cornell Graduate School of Medical Sciences, immersed in structural biology and biochemistry. His educational journey investigating proteins involved in metabolism and DNA replication was intellectually rewarding, but it was also bookended by uncertainty and...

Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than did semaglutide (trade name Wegovy) in a clinical trial that compared the safety and efficacy of the injectable drugs. In the 72-week trial—led by an investigator at Weill Cornell Medicine and NewYork-Presbyterian and conducted with the University of Texas McGovern Medical School, the David Geffen School of Medicine at the University of California, Los Angeles, the University College Dublin and...

A new artificial intelligence-based method accurately sorts cancer patients into groups that have similar characteristics before treatment and similar outcomes after treatment, according to a study led by investigators at Weill Cornell Medicine. The new approach has the potential to enable better patient selection in clinical trials and better treatment selection for individual patients.

The study, published May 12 in...

Using machine learning technology, a new study has identified three distinct profiles describing social and economic factors that are associated with a higher risk of suicide. Scientists at Weill Cornell Medicine and Columbia University Vagelos College of Physicians and Surgeons led the research that showed suicide rates vary significantly across the three clusters and that the patterns differ geographically across the United States.

The...

Weill Cornell Medicine has received a projected $4 million grant from the National Cancer Institute, part of the National Institutes of Health, to conduct a clinical trial testing whether a new imaging approach could reduce the need for biopsies to monitor prostate cancer.

The five-year grant, with a possible two-year extension, will evaluate whether adding an imaging modality called Prostate Specific Membrane Antigen (PSMA)- Positron Emission Tomography (PET) Computed Tomography (CT) ...

Weill Cornell Medicine-Qatar awarded Cornell University medical degrees to 45 new doctors during the institution’s commencement ceremony May 7.

The Class of 2025 comprised 28 women and 17 men who hail from 19 countries around the world, including 13 Qatari nationals. To date, WCM-Q has graduated 641 new doctors since its inaugural graduation ceremony in 2008.

“It is a great honor to be here to congratulate the Class of 2025 on their outstanding achievements,” said Cornell...

A tiny chemical modification commonly found on messenger RNAs plays a surprisingly large role in how cells respond to stress, according to a study led by Weill Cornell Medicine investigators.  The finding clarifies an important aspect of cell biology, and may have clinical implications, since this messenger RNA modification, known as m6A, is the target of an emerging class of cancer treatments.

Messenger RNA (mRNA)—the molecule that carries genetic instructions to make proteins—is...

As a third-year medical student, Stone Streeter cut his teeth during his medical education at Weill Cornell Medicine while living in the institution’s student housing—first at Olin Hall during his classroom instruction, then at Lasdon House for his clerkships. As he eyes his last year at Weill Cornell Medical College, he’s preparing for yet another move: to the Feil Family and Weill Family Residence Hall.

“Now, I’m standing here today, a mosaic of past experiences, ready to tackle the...

Teams of health care providers called Accountable Care Organizations participating in the Medicare Shared Savings Program have saved Medicare between $4.1 billion and $8.1 billion from 2012 through 2019, according to a new study from Weill Cornell Medicine investigators. The study, published April 28 in JAMA, is thought to be the first to investigate the long-term impact of the program.

Launched in 2012, the...

Three distinguished Weill Cornell Medicine physician-scientists, Dr. Matthew Greenblatt, Dr. Lishomwa Ndhlovu and Dr. Sallie Permar, have been elected to the prestigious Association of American Physicians (AAP).

Regarded as one of the top honors in the field of health and medicine, election to the AAP recognizes physician-scientists who exhibit excellence in the pursuit of medical knowledge and the advancement of basic or translational science through experimentation and discovery and...

In 2023, tuberculosis (TB) killed about 1.25 million people worldwide, more than any other infectious disease on Earth — even though it is curable. Months- or even years-long regimens of potent antibiotics can eradicate the Mycobacterium tuberculosis bacteria. And in about...

A major new effort at Weill Cornell Medicine seeks to catalog the normal human virome, the immense ecosystem of viruses that lives in and on us. The work, part of a multi-institution collaboration called Viromes Across Space and Time (VAST), supported by the National Institute on Aging, part of the National Institutes of Health, will pioneer new techniques, illuminate a crucial aspect of human biology that was impossible to study before, and establish a baseline set of data that could help...

The way DNA folds inside the nucleus of brain cells may hold the key to understanding a devastating form of brain cancer called glioblastoma, suggests a new preclinical study from Weill Cornell Medicine researchers. The findings, published April 3 in Molecular Cell, offer a new way to think about cancer beyond gene mutations,...

A new study from Weill Cornell Medicine provides insights into how cells maintain the tiny end caps of chromosomes as they divide, a key process in keeping cells healthy. Using yeast, the researchers reveal protein interactions that could explain how the enzyme telomerase is tightly regulated to prevent cells from dividing uncontrollably or aging prematurely. The preclinical study, published April 17 in Nucleic...

Bacteria naturally present in the human intestine, known as the gut microbiota, can transform cholesterol-derived bile acids into powerful metabolites that strengthen anti-cancer immunity by blocking androgen signaling, according to a preclinical study led by Weill Cornell Medicine investigators. The study was published on April 15 in Cell.

Nearly 200 scientists, investors and industry representatives attended Weill Cornell Medicine’s 2025 Biomedical Innovation Conference (“BioInnovate”) April 1, sharing their startup journeys and experiences nurturing biomedical advances into health care products and companies.

The conference, hosted in the institution’s Uris Auditorium, featured a fireside chat with venture capitalist Alex Gorsky, general partner at investment firm ICONIQ Growth and the former...